Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report

The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement

Leif Bergkvist, Hans‐Olov Adami, Ingemar Persson et al. · New England Journal of Medicine · 1989 · 619 citations

Medicine, Endocrinology, Oncology +13

Contrasting Effects of Oral and Transdermal Routes of Estrogen Replacement Therapy on 24-Hour Growth Hormone (GH) Secretion, Insulin-Like Growth Factor I, and GH-Binding Protein in Postmenopausal Women*

Andrew J. Weissberger, Ken K. Y. Ho, Leslie Lazarus · The Journal of Clinical Endocrinology & Metabolism · 1991 · 516 citations

Life Sciences, Biochemistry, Endocrinology +17

Noncontraceptive estrogens and progestins: use patterns over time.

Kennedy Dl, Carlene Baum, Forbes Mb · PubMed · 1985 · 143 citations

Medicine, Endocrinology, Gynecology +14

Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study

Graham A. Colditz, Meir J. Stampfer, Walter C. Willett et al. · Cancer Causes & Control · 1992 · 126 citations

Medicine, Endocrinology, Oncology +9

Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.

V. Craig Jordan, Nancy F. Fritz, D C Tormey · PubMed · 1987 · 119 citations

Medicine, Oncology, Pharmacology +15